Dr. Monika Laszkowska, a gastroenterology fellow, next to the poster she presented at the 2019 TargetCancer Foundation Think Tank on Advancing...
An Insider’s Perspective
read more
OnTarget
A Rare Cancer Blog
2019 Cholangiocarcinoma Research Grant Announcement
TargetCancer Foundation is proud to announce a new two-year, $240,000 grant to the Bardeesy Lab at the Massachusetts General Hospital Cancer Center brings our...
Building the Tools of Cholangiocarcinoma Research – A Researcher’s Reflection.
In December 2019, TargetCancer Foundation announced $240,000 in new cholangiocarcinoma grant funding. The following post was written by Grant Recipient Nabeel...
10 Years Ago Today
Today TargetCancer Foundation remembers our founder, Paul Poth, whose life was taken by cholangiocarcinoma at age 39 on this day ten years ago- August 22,...
Teeing off for TargetCancer Foundation
By TargetCancer Foundation 2019 Summer Intern Ollie Cheever The fifth annual Matt Lindsay Memorial Golf Tournament tees off this Saturday, August 3rd, at the...
A Holiday Reflection
By Alie Plouff, TargetCancer Foundation Advocacy Council Member Like many things in life, grief isn’t black and white. In fact, it is mostly one large gray...
2018 NORD Summit: An Advocate’s Perspective
By Leslie Condon, TargetCancer Foundation Advocacy Council Chair The National Organization for Rare Disorders was formed after a small coalition of rare...
Team TargetCancer Foundation returns to the 2019 Boston Marathon!
We are happy to announce that Team TargetCancer Foundation will be making its fifth appearance in the Boston Marathon in 2019! We are excited to return to...
Facebook Fundraisers
Did you know that Facebook makes it incredibly easy to engage your community to raise funds for TargetCancer Foundation? You can create a fundraiser to...
A New Patient-Partnered Initiative Launches.
We are tremendously proud to announce the launch of the Gastroesophageal Cancer Project, a new, innovative patient partnered research initiative. The...
ASCO 2018: An Advocate’s Perspective
By TargetCancer Foundation Advocacy Council Chair Leslie Condon When I walked into McCormick Place on the first day of this year’s annual ASCO Conference, I...
Always Remember you Should be Heard: A Journey from Caregiver, to Patient, to Advocate
By Guest Blogger Dana Deighton Though my 25 years of professional experiences are mostly rooted in marketing, the last 15 years or so of my personal life have...
Considering Whether Criteria for Clinical Trials Exclude Too Many Patients
Clinical trials are a critical part of the development of new treatments. They rely on people who volunteer to participate and are then closely monitored by...
Announcing New 2018 Grants
As our programs at TargetCancer Foundation continue to expand, we remain committed to our primary mission of funding innovative rare cancer research. We are...
Running Against Cholangiocarcinoma in the 2018 Boston Marathon
By Karen Dempsey, TargetCancer Foundation Advocacy Council Member Though researchers classify cholangiocarcinoma as a rare cancer, we know the reach of the...